CA2075493A1 - Amorces pcr pour la detection de l'espece legionella et methodes permettant de regler l'intensite visuelle dans les essais d'hybridation - Google Patents

Amorces pcr pour la detection de l'espece legionella et methodes permettant de regler l'intensite visuelle dans les essais d'hybridation

Info

Publication number: CA2075493A1
Authority: CA; Canada
Prior art keywords: nucleic acid; primers; primer; probes; capture
Prior art date: 1990-12-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002075493A

Other languages

English (en)

Inventor

Teresa K. H. Picone

Theresa Mccallum

Michael A. Zoccoli

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

F Hoffmann La Roche AG

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-20

Filing date

1991-12-19

Publication date

1992-06-21

1991-12-19 Application filed by Individual filed Critical Individual

1992-06-21 Publication of CA2075493A1 publication Critical patent/CA2075493A1/fr

Status Abandoned legal-status Critical Current

Links

238000001514 detection method Methods 0.000 title claims abstract description 97
238000000034 method Methods 0.000 title claims abstract description 72
241000589248 Legionella Species 0.000 title claims abstract description 63
238000003556 assay Methods 0.000 title claims abstract description 40
230000000007 visual effect Effects 0.000 title claims abstract description 37
238000009396 hybridization Methods 0.000 title claims description 41
239000000523 sample Substances 0.000 claims abstract description 258
150000007523 nucleic acids Chemical class 0.000 claims abstract description 164
108020004707 nucleic acids Proteins 0.000 claims abstract description 152
102000039446 nucleic acids Human genes 0.000 claims abstract description 152
230000003321 amplification Effects 0.000 claims abstract description 49
238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 49
239000007787 solid Substances 0.000 claims abstract description 31
230000008569 process Effects 0.000 claims abstract description 22
238000007899 nucleic acid hybridization Methods 0.000 claims abstract description 20
238000002156 mixing Methods 0.000 claims abstract description 6
239000000203 mixture Substances 0.000 claims description 56
108091034117 Oligonucleotide Proteins 0.000 claims description 40
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims description 18
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims description 18
230000027455 binding Effects 0.000 claims description 14
230000000295 complement effect Effects 0.000 claims description 13
239000013641 positive control Substances 0.000 claims description 13
238000012360 testing method Methods 0.000 claims description 13
239000002773 nucleotide Substances 0.000 claims description 12
125000003729 nucleotide group Chemical group 0.000 claims description 11
229940104302 cytosine Drugs 0.000 claims description 9
229940113082 thymine Drugs 0.000 claims description 9
108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 7
102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 7
238000012408 PCR amplification Methods 0.000 claims description 6
229930024421 Adenine Natural products 0.000 claims description 3
229960000643 adenine Drugs 0.000 claims description 3
GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 3
238000011144 upstream manufacturing Methods 0.000 claims description 3
239000002253 acid Substances 0.000 claims description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical group O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims 4
208000007764 Legionnaires' Disease Diseases 0.000 abstract description 40
238000006243 chemical reaction Methods 0.000 abstract description 14
230000001717 pathogenic effect Effects 0.000 abstract description 9
230000015572 biosynthetic process Effects 0.000 abstract description 7
230000001419 dependent effect Effects 0.000 abstract description 5
239000013615 primer Substances 0.000 description 114
238000003752 polymerase chain reaction Methods 0.000 description 40
108020004414 DNA Proteins 0.000 description 39
241000894007 species Species 0.000 description 33
241000589242 Legionella pneumophila Species 0.000 description 22
101150075489 mip gene Proteins 0.000 description 20
108020005075 5S Ribosomal RNA Proteins 0.000 description 19
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
102000004190 Enzymes Human genes 0.000 description 16
108090000790 Enzymes Proteins 0.000 description 16
239000012528 membrane Substances 0.000 description 16
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 13
108090000623 proteins and genes Proteins 0.000 description 13
101100457322 Rattus norvegicus Mipep gene Proteins 0.000 description 12
239000003153 chemical reaction reagent Substances 0.000 description 11
239000011541 reaction mixture Substances 0.000 description 11
239000000243 solution Substances 0.000 description 11
108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
239000004677 Nylon Substances 0.000 description 9
229920001778 nylon Polymers 0.000 description 9
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
238000002844 melting Methods 0.000 description 8
230000008018 melting Effects 0.000 description 8
239000000872 buffer Substances 0.000 description 7
210000004027 cell Anatomy 0.000 description 7
108091028043 Nucleic acid sequence Proteins 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
230000001276 controlling effect Effects 0.000 description 6
238000004925 denaturation Methods 0.000 description 6
230000036425 denaturation Effects 0.000 description 6
229940115932 legionella pneumophila Drugs 0.000 description 6
239000000126 substance Substances 0.000 description 6
239000000758 substrate Substances 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
241000589516 Pseudomonas Species 0.000 description 5
108010090804 Streptavidin Proteins 0.000 description 5
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 5
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 5
108010006785 Taq Polymerase Proteins 0.000 description 5
238000002820 assay format Methods 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
239000000499 gel Substances 0.000 description 5
238000002372 labelling Methods 0.000 description 5
-1 nucleoside triphosphates Chemical class 0.000 description 5
238000000926 separation method Methods 0.000 description 5
238000004448 titration Methods 0.000 description 5
239000001226 triphosphate Substances 0.000 description 5
235000011178 triphosphate Nutrition 0.000 description 5
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
108010001336 Horseradish Peroxidase Proteins 0.000 description 4
102100034343 Integrase Human genes 0.000 description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
229960002685 biotin Drugs 0.000 description 4
235000020958 biotin Nutrition 0.000 description 4
239000011616 biotin Substances 0.000 description 4
238000011161 development Methods 0.000 description 4
238000010438 heat treatment Methods 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
210000002540 macrophage Anatomy 0.000 description 4
108091027963 non-coding RNA Proteins 0.000 description 4
102000042567 non-coding RNA Human genes 0.000 description 4
244000052769 pathogen Species 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
230000004044 response Effects 0.000 description 4
230000035945 sensitivity Effects 0.000 description 4
241000589259 Legionella feeleii Species 0.000 description 3
241001135522 Legionella sainthelensi Species 0.000 description 3
108020004711 Nucleic Acid Probes Proteins 0.000 description 3
238000009835 boiling Methods 0.000 description 3
239000012141 concentrate Substances 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
230000007613 environmental effect Effects 0.000 description 3
230000003834 intracellular effect Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
239000002853 nucleic acid probe Substances 0.000 description 3
239000002777 nucleoside Substances 0.000 description 3
230000000379 polymerizing effect Effects 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
239000002987 primer (paints) Substances 0.000 description 3
238000005070 sampling Methods 0.000 description 3
239000001509 sodium citrate Substances 0.000 description 3
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 2
244000105975 Antidesma platyphyllum Species 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
108020004635 Complementary DNA Proteins 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
230000004544 DNA amplification Effects 0.000 description 2
108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 2
102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 2
230000006820 DNA synthesis Effects 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
241000589244 Fluoribacter bozemanae Species 0.000 description 2
241000589282 Fluoribacter dumoffii Species 0.000 description 2
241000589278 Fluoribacter gormanii Species 0.000 description 2
NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
241000589240 Legionella hackeliae Species 0.000 description 2
241000589276 Legionella jordanis Species 0.000 description 2
241000589264 Legionella longbeachae Species 0.000 description 2
241000189497 Legionella parisiensis Species 0.000 description 2
241000589246 Legionellaceae Species 0.000 description 2
108060004795 Methyltransferase Proteins 0.000 description 2
101710163270 Nuclease Proteins 0.000 description 2
102000003992 Peroxidases Human genes 0.000 description 2
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
238000000137 annealing Methods 0.000 description 2
238000013459 approach Methods 0.000 description 2
238000003149 assay kit Methods 0.000 description 2
238000010804 cDNA synthesis Methods 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
230000009089 cytolysis Effects 0.000 description 2
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
230000007423 decrease Effects 0.000 description 2
239000005547 deoxyribonucleotide Substances 0.000 description 2
239000000975 dye Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
229960005542 ethidium bromide Drugs 0.000 description 2
238000000605 extraction Methods 0.000 description 2
238000001914 filtration Methods 0.000 description 2
239000011521 glass Substances 0.000 description 2
235000009424 haa Nutrition 0.000 description 2
230000036039 immunity Effects 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
238000002955 isolation Methods 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
230000002934 lysing effect Effects 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
239000013642 negative control Substances 0.000 description 2
230000007918 pathogenicity Effects 0.000 description 2
108040007629 peroxidase activity proteins Proteins 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
238000006116 polymerization reaction Methods 0.000 description 2
239000011148 porous material Substances 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
239000011347 resin Substances 0.000 description 2
229920005989 resin Polymers 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
238000010186 staining Methods 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
239000002351 wastewater Substances 0.000 description 2
IACFXVUNKCXYJM-AKSHDPDZSA-N 2-(chloromethyl)oxirane (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound ClCC1CO1.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 IACFXVUNKCXYJM-AKSHDPDZSA-N 0.000 description 1
YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
241000713838 Avian myeloblastosis virus Species 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
239000002126 C01EB10 - Adenosine Substances 0.000 description 1
MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
PJWWRFATQTVXHA-UHFFFAOYSA-N Cyclohexylaminopropanesulfonic acid Chemical compound OS(=O)(=O)CCCNC1CCCCC1 PJWWRFATQTVXHA-UHFFFAOYSA-N 0.000 description 1
NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
238000007400 DNA extraction Methods 0.000 description 1
AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
241000589565 Flavobacterium Species 0.000 description 1
206010016952 Food poisoning Diseases 0.000 description 1
208000019331 Foodborne disease Diseases 0.000 description 1
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
108010062347 HLA-DQ Antigens Proteins 0.000 description 1
241001135524 Legionella anisa Species 0.000 description 1
241001135525 Legionella birminghamensis Species 0.000 description 1
241001135526 Legionella cherrii Species 0.000 description 1
241000589239 Legionella erythra Species 0.000 description 1
241000189481 Legionella gratiana Species 0.000 description 1
241000589274 Legionella jamestowniensis Species 0.000 description 1
241000589293 Legionella maceachernii Species 0.000 description 1
241001534810 Legionella moravica Species 0.000 description 1
241001148224 Legionella oakridgensis Species 0.000 description 1
241000189495 Legionella quinlivanii Species 0.000 description 1
241000189518 Legionella santicrucis Species 0.000 description 1
241000589263 Legionella spiritensis Species 0.000 description 1
241000122902 Legionella tucsonensis Species 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
239000012807 PCR reagent Substances 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
239000004365 Protease Substances 0.000 description 1
241000588767 Proteus vulgaris Species 0.000 description 1
241000589540 Pseudomonas fluorescens Species 0.000 description 1
239000013616 RNA primer Substances 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
101150093282 SG12 gene Proteins 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
241000607768 Shigella Species 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
241000589262 Tatlockia micdadei Species 0.000 description 1
239000004809 Teflon Substances 0.000 description 1
229920006362 Teflon® Polymers 0.000 description 1
241000589500 Thermus aquaticus Species 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
241000607598 Vibrio Species 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
229960005305 adenosine Drugs 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
238000004378 air conditioning Methods 0.000 description 1
125000003275 alpha amino acid group Chemical group 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000000427 antigen Substances 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
239000012062 aqueous buffer Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
230000000712 assembly Effects 0.000 description 1
238000000429 assembly Methods 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
230000008901 benefit Effects 0.000 description 1
229940092714 benzenesulfonic acid Drugs 0.000 description 1
239000012472 biological sample Substances 0.000 description 1
229910021538 borax Inorganic materials 0.000 description 1
UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
239000000337 buffer salt Substances 0.000 description 1
230000003139 buffering effect Effects 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
230000008859 change Effects 0.000 description 1
239000012468 concentrated sample Substances 0.000 description 1
238000001816 cooling Methods 0.000 description 1
230000037029 cross reaction Effects 0.000 description 1
230000001351 cycling effect Effects 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
230000002498 deadly effect Effects 0.000 description 1
239000003398 denaturant Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
239000003599 detergent Substances 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
229960000633 dextran sulfate Drugs 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
229940096118 ella Drugs 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
239000013505 freshwater Substances 0.000 description 1
229940029575 guanosine Drugs 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
239000002198 insoluble material Substances 0.000 description 1
230000002427 irreversible effect Effects 0.000 description 1
230000000155 isotopic effect Effects 0.000 description 1
229940059904 light mineral oil Drugs 0.000 description 1
239000012160 loading buffer Substances 0.000 description 1
238000000464 low-speed centrifugation Methods 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
238000007403 mPCR Methods 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
SXADIBFZNXBEGI-UHFFFAOYSA-N phosphoramidous acid Chemical compound NP(O)O SXADIBFZNXBEGI-UHFFFAOYSA-N 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000011045 prefiltration Methods 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000037452 priming Effects 0.000 description 1
229940007042 proteus vulgaris Drugs 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000012429 reaction media Substances 0.000 description 1
239000012088 reference solution Substances 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
238000012552 review Methods 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
230000035939 shock Effects 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
235000010339 sodium tetraborate Nutrition 0.000 description 1
238000000527 sonication Methods 0.000 description 1
238000011895 specific detection Methods 0.000 description 1
239000012086 standard solution Substances 0.000 description 1
230000003068 static effect Effects 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000012085 test solution Substances 0.000 description 1
238000005382 thermal cycling Methods 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 1
238000012800 visualization Methods 0.000 description 1
239000011534 wash buffer Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Analytical Chemistry (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA002075493A 1990-12-20 1991-12-19 Amorces pcr pour la detection de l'espece legionella et methodes permettant de regler l'intensite visuelle dans les essais d'hybridation Abandoned CA2075493A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US63089990A	1990-12-20	1990-12-20
US630,899		1990-12-20
PCT/US1991/009688 WO1992011273A1 (fr)	1990-12-20	1991-12-19	Amorces d'amplification enzymatique du genome pour la detection des especes legionella et procedes de controle de l'intensite d'un signal visuel dans des dosages d'hybridation

Publications (1)

Publication Number	Publication Date
CA2075493A1 true CA2075493A1 (fr)	1992-06-21

Family

ID=24529011

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002075493A Abandoned CA2075493A1 (fr)	1990-12-20	1991-12-19	Amorces pcr pour la detection de l'espece legionella et methodes permettant de regler l'intensite visuelle dans les essais d'hybridation

Country Status (5)

Country	Link
EP (1)	EP0533854A4 (fr)
JP (1)	JPH05507206A (fr)
AU (1)	AU657286B2 (fr)
CA (1)	CA2075493A1 (fr)
WO (1)	WO1992011273A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5470723A (en) *	1993-05-05	1995-11-28	Becton, Dickinson And Company	Detection of mycobacteria by multiplex nucleic acid amplification
US5457027A (en) *	1993-05-05	1995-10-10	Becton, Dickinson And Company	Internal controls for isothermal nucleic acid amplification reactions
US6174668B1 (en) *	1993-05-14	2001-01-16	Johnson & Johnson Clinical Diagnostics, Inc.	Diagnostic compositions, elements, methods and test kits for amplification and detection of two or more target DNA's using primers having matched melting temperatures
EP0630973A3 (fr) *	1993-05-14	1995-04-26	Eastman Kodak Co	Compositions de diagnostic, éléments, procédés et kits pour tests d'amplification et de détection de deux ou plusieurs ADN's utilisant des amorces à températures de fusion-adaptés.
US20020055101A1 (en)	1995-09-11	2002-05-09	Michel G. Bergeron	Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
DE19515891C2 (de) *	1995-04-29	1999-10-28	Roche Diagnostics Gmbh	Gattungs- und speziesspezifische Identifizierung von Legionellen
US20030049636A1 (en)	1999-05-03	2003-03-13	Bergeron Michel G.	Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
US20100267012A1 (en)	1997-11-04	2010-10-21	Bergeron Michel G	Highly conserved genes and their use to generate probes and primers for detection of microorganisms
US5968739A (en) *	1996-12-10	1999-10-19	Abbott Laboratories	Nucleic acid primers and probes for detecting Legionella pneumophila
FR2775002B1 (fr) *	1998-02-19	2003-01-10	France Etat	Procede de diagnostic d'agents pathogenes respiratoires par biologie moleculaire
EP2322668A3 (fr)	1999-09-28	2011-10-05	Geneohm Sciences Canada Inc.	GENE A FORT POUVOIR DE CONSERVATION ET l'UTILISATION POUR PRODUIRE DES SONDES D'ACIDE NUCLEIQUE SPECIFIQUES A L'ESPECE, SPECIFIQUES AU GENE, SPECIFIQUES A LA FAMILLE, SPECIFIQUES AU GROUPE ET UNIVERSELLES ET DES SONDES D'AMPLIFICATION, EN VUE DE DETECTER ET D'IDENTIFIER RAPIDEMENT DES MICRO-ORGANISMES
FR2801677B1 (fr) *	1999-11-30	2003-04-25	Ulp Ct D Analyses Et De Rech S	Procede d'analyse d'un echantillon pour la presence eventuelle de legionelles comprenant une etape d'immunocapture
US7368246B2 (en)	2005-09-15	2008-05-06	Primera Biosystems, Inc.	Quantitative gene expression profiling
EP1939304A1 (fr) *	2006-12-29	2008-07-02	Nederlandse Organisatie voor Toegepast-Natuuurwetenschappelijk Onderzoek TNO	Procédé de détection de souches de légionellose pathogéniques
EP2385990A4 (fr) *	2008-12-18	2012-08-01	Us Gov Health & Human Serv	Détection de réaction en chaine par polymérase en temps réel de legionella pneumophila et forme de différenciation d'autres espèces de legionella
FR2960552B1 (fr) *	2010-06-01	2015-08-07	Ct Europ D Expertise Et De Rech Sur Les Agents Microbiens Ceeram	Procede de genotypage de legionella pneumophila
DE102018213027A1 (de) *	2018-08-03	2020-02-06	Robert Bosch Gmbh	Reaktionsgemisch, Verfahren und Kit zur Durchführung einer quantitativen Echtzeit-PCR
CN115029452B (zh) *	2021-11-16	2024-03-22	江汉大学	一种军团菌属的mnp标记位点、引物组合物、试剂盒及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4683195A (en) *	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
AU616646B2 (en) *	1986-11-24	1991-11-07	Gen-Probe Incorporated	Nucleic acid probes for detection and/or quantitation of non-viral organisms
US5004682A (en) *	1987-11-02	1991-04-02	Olin Corporation	Method and kit for detecting live microorganisms in chlorine- or bromine-treated water
US4902624A (en) *	1987-11-23	1990-02-20	Eastman Kodak Company	Temperature cycling cuvette
CA2033718A1 (fr) *	1990-01-19	1991-07-20	Ronald M. Atlas	Procede de detection d'agents pathogenes microbiens dans l'eau et indicateurs de contamination par des matieres fecales humaines dans des echantillons d'eau et trousses de detection connexes

1991
- 1991-12-19 CA CA002075493A patent/CA2075493A1/fr not_active Abandoned
- 1991-12-19 AU AU91567/91A patent/AU657286B2/en not_active Ceased
- 1991-12-19 WO PCT/US1991/009688 patent/WO1992011273A1/fr not_active Ceased
- 1991-12-19 EP EP19920903210 patent/EP0533854A4/en not_active Withdrawn
- 1991-12-19 JP JP92503754A patent/JPH05507206A/ja active Pending

Also Published As

Publication number	Publication date
EP0533854A4 (en)	1994-06-08
WO1992011273A1 (fr)	1992-07-09
EP0533854A1 (fr)	1993-03-31
JPH05507206A (ja)	1993-10-21
AU9156791A (en)	1992-07-22
AU657286B2 (en)	1995-03-09

Publication	Publication Date	Title
US5491225A (en)	1996-02-13	PCR primers for detection of legionella species and methods for controlling visual intensity in hybridization assays
AU657286B2 (en)	1995-03-09	PCR primers for detection of legionella species and methods for controlling visual intensity in hybridization assays
AU702237B2 (en)	1999-02-18	Universal targets for species identification
EP0571911A2 (fr)	1993-12-01	Sondes pour mycobactéries
EP0556504B1 (fr)	2001-07-25	Oligonucléotides pour la détection de Vibrio parahaemolyticus
EP0619375B1 (fr)	2000-08-09	Détection et identification de mycobactéries
NZ243921A (en)	1994-01-26	NUCLEOTIDE PROBE FOR THE 16S-rRNA GENE OF MYCOBACTERIA.
AU710387B2 (en)	1999-09-16	Amplification and detection of mycobacterium avium complex species
AU690294B2 (en)	1998-04-23	Species-specific detection of Mycobacterium kansasii
JP2007500517A (ja)	2007-01-18	核酸増幅系に用いる内部コントロール核酸分子
EP0915170B1 (fr)	2003-05-14	Système d' analyse de Chlamydia Trachomatis par amplification et détection de plasmide cryptique de Chlamydia Trachomatis
US6251609B1 (en)	2001-06-26	Amplification and detection of Legionella pneumophila targeting the mip gene
US5518884A (en)	1996-05-21	Nucleic acid sequences specific for mycbacterium kansasii
JP2792462B2 (ja)	1998-09-03	サルモネラ属菌検出のためのオリゴヌクレオチドおよびそれを用いた検出法
US5968739A (en)	1999-10-19	Nucleic acid primers and probes for detecting Legionella pneumophila
US6277582B1 (en)	2001-08-21	Amplification and detection of mycoplasma pneumoniae targeting the P1 gene
US20090075286A1 (en)	2009-03-19	Detection of Polyketide Synthetase Gene Expression in Karenia Brevis
US6261785B1 (en)	2001-07-17	Amplification and detection of Bordetella pertussis
US5723296A (en)	1998-03-03	Amplification and detection of mycobacterial DNA K nucleic acids
EP0517154A1 (fr)	1992-12-09	Procédé de détection de giardia
JP4782784B2 (ja)	2011-09-28	病原性大腸菌の検出および識別のためのｄｎａ配列
WO2008137715A1 (fr)	2008-11-13	Détection de la résistance au triazole dans l'aspergillus
JPH11239484A (ja)	1999-09-07	ウエルシュ菌検出用オリゴヌクレオチドおよびそれを用いた検出法

Legal Events

Date	Code	Title	Description
1997-12-19	FZDE	Dead